APO Research
Talk to an analyst

APO RESEARCH · REPORT

Specialty Generics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Specialty Generics Industry Growth and Trends Forecast to 2032

31 December 2025100 pages

Choose your research edition.

Industry ResearchSpecialty Generics Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Specialty Generics Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Specialty Generics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Specialty Generics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Specialty Generics Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Specialty Generics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Specialty Generics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Specialty Generics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Specialty Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Specialty Generics include Akorn, Inc., Apotex Corp., Endo International plc., Mallinckrodt, Sandoz International GmbH, Valeant Pharmaceuticals, Pfizer, Inc., Mylan N.V. and Sun Pharmaceutical Industries Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Specialty Generics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Specialty Generics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Specialty Generics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Specialty Generics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Specialty Generics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Specialty Generics Market by Company

Akorn, Inc.

Apotex Corp.

Endo International plc.

Mallinckrodt

Sandoz International GmbH

Valeant Pharmaceuticals

Pfizer, Inc.

Mylan N.V.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceuticals Industries

Specialty Generics Segment by Type

Injectables

Oral

Others

Specialty Generics Segment by Application

Retail Pharmacies

Hospital Pharmacies

Specialty Pharmacies

Specialty Generics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Specialty Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Specialty Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Specialty Generics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Specialty Generics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Specialty Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injectables Table 2. Major Company of Oral Table 3. Major Company of Others Table 4. Global Specialty Generics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Specialty Generics Sales by Type (2021-2026) & (K Units) Table 6. Global Specialty Generics Sales Market Share in Volume by Type (2021-2026) Table 7. Global Specialty Generics Sales by Type (2021-2026) & (US$ Million) Table 8. Global Specialty Generics Sales Market Share in Value by Type (2021-2026) Table 9. Global Specialty Generics Price by Type (2021-2026) & (US$/Unit) Table 10. Global Specialty Generics Sales by Type (2027-2032) & (K Units) Table 11. Global Specialty Generics Sales Market Share in Volume by Type (2027-2032) Table 12. Global Specialty Generics Sales by Type (2027-2032) & (US$ Million) Table 13. Global Specialty Generics Sales Market Share in Value by Type (2027-2032) Table 14. Global Specialty Generics Price by Type (2027-2032) & (US$/Unit) Table 15. North America Specialty Generics Sales by Type (2021-2026) & (K Units) Table 16. North America Specialty Generics Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Specialty Generics Sales by Type (2021-2026) & (K Units) Table 18. Europe Specialty Generics Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Specialty Generics Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Specialty Generics Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Specialty Generics Sales by Type (2021-2026) & (K Units) Table 22. Latin America Specialty Generics Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Specialty Generics Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Specialty Generics Sales by Type (2021-2026) & (US$ Million) Table 25. Specialty Generics Industry Trends Table 26. Specialty Generics Industry Drivers Table 27. Specialty Generics Industry Opportunities and Challenges Table 28. Specialty Generics Industry Restraints Table 29. Global Specialty Generics Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Specialty Generics Revenue Market Share by Company (2021-2026) Table 31. Global Specialty Generics Sales by Company (2021-2026) & (K Units) Table 32. Global Specialty Generics Sales Share by Company (2021-2026) Table 33. Global Specialty Generics Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Specialty Generics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Specialty Generics Major Company Production Sites and Headquarters Table 36. Global Specialty Generics Company, Product Type & Application Table 37. Global Specialty Generics Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Specialty Generics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Specialty Generics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Specialty Generics Sales by Region (2021-2026) & (K Units) Table 42. Global Specialty Generics Sales Market Share in Volume by Region (2021-2026) Table 43. Global Specialty Generics Sales by Region (2021-2026) & (US$ Million) Table 44. Global Specialty Generics Sales Market Share in Value by Region (2021-2026) Table 45. Global Specialty Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Specialty Generics Sales by Region (2027-2032) & (K Units) Table 47. Global Specialty Generics Sales Market Share in Volume by Region (2027-2032) Table 48. Global Specialty Generics Sales by Region (2027-2032) & (US$ Million) Table 49. Global Specialty Generics Sales Market Share in Value by Region (2027-2032) Table 50. Global Specialty Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Specialty Generics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Specialty Generics Sales by Application (2021-2026) & (K Units) Table 53. Global Specialty Generics Sales Market Share in Volume by Application (2021-2026) Table 54. Global Specialty Generics Sales by Application (2021-2026) & (US$ Million) Table 55. Global Specialty Generics Sales Market Share in Value by Application (2021-2026) Table 56. Global Specialty Generics Price by Application (2021-2026) & (US$/Unit) Table 57. Global Specialty Generics Sales by Application (2027-2032) & (K Units) Table 58. Global Specialty Generics Sales Market Share in Volume by Application (2027-2032) Table 59. Global Specialty Generics Sales by Application (2027-2032) & (US$ Million) Table 60. Global Specialty Generics Sales Market Share in Value by Application (2027-2032) Table 61. Global Specialty Generics Price by Application (2027-2032) & (US$/Unit) Table 62. North America Specialty Generics Sales by Application (2021-2026) & (K Units) Table 63. North America Specialty Generics Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Specialty Generics Sales by Application (2021-2026) & (K Units) Table 65. Europe Specialty Generics Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Specialty Generics Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Specialty Generics Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Specialty Generics Sales by Application (2021-2026) & (K Units) Table 69. Latin America Specialty Generics Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Specialty Generics Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Specialty Generics Sales by Application (2021-2026) & (US$ Million) Table 72. Akorn, Inc. Company Information Table 73. Akorn, Inc. Business Overview Table 74. Akorn, Inc. Specialty Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Akorn, Inc. Specialty Generics Product Portfolio Table 76. Akorn, Inc. Recent Development Table 77. Apotex Corp. Company Information Table 78. Apotex Corp. Business Overview Table 79. Apotex Corp. Specialty Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Apotex Corp. Specialty Generics Product Portfolio Table 81. Apotex Corp. Recent Development Table 82. Endo International plc. Company Information Table 83. Endo International plc. Business Overview Table 84. Endo International plc. Specialty Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Endo International plc. Specialty Generics Product Portfolio Table 86. Endo International plc. Recent Development Table 87. Mallinckrodt Company Information Table 88. Mallinckrodt Business Overview Table 89. Mallinckrodt Specialty Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Mallinckrodt Specialty Generics Product Portfolio Table 91. Mallinckrodt Recent Development Table 92. Sandoz International GmbH Company Information Table 93. Sandoz International GmbH Business Overview Table 94. Sandoz International GmbH Specialty Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sandoz International GmbH Specialty Generics Product Portfolio Table 96. Sandoz International GmbH Recent Development Table 97. Valeant Pharmaceuticals Company Information Table 98. Valeant Pharmaceuticals Business Overview Table 99. Valeant Pharmaceuticals Specialty Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Valeant Pharmaceuticals Specialty Generics Product Portfolio Table 101. Valeant Pharmaceuticals Recent Development Table 102. Pfizer, Inc. Company Information Table 103. Pfizer, Inc. Business Overview Table 104. Pfizer, Inc. Specialty Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Pfizer, Inc. Specialty Generics Product Portfolio Table 106. Pfizer, Inc. Recent Development Table 107. Mylan N.V. Company Information Table 108. Mylan N.V. Business Overview Table 109. Mylan N.V. Specialty Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Mylan N.V. Specialty Generics Product Portfolio Table 111. Mylan N.V. Recent Development Table 112. Sun Pharmaceutical Industries Ltd. Company Information Table 113. Sun Pharmaceutical Industries Ltd. Business Overview Table 114. Sun Pharmaceutical Industries Ltd. Specialty Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Sun Pharmaceutical Industries Ltd. Specialty Generics Product Portfolio Table 116. Sun Pharmaceutical Industries Ltd. Recent Development Table 117. Teva Pharmaceuticals Industries Company Information Table 118. Teva Pharmaceuticals Industries Business Overview Table 119. Teva Pharmaceuticals Industries Specialty Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Teva Pharmaceuticals Industries Specialty Generics Product Portfolio Table 121. Teva Pharmaceuticals Industries Recent Development Table 122. North America Specialty Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America Specialty Generics Sales by Country (2021-2026) & (K Units) Table 124. North America Specialty Generics Sales Market Share by Country (2021-2026) Table 125. North America Specialty Generics Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America Specialty Generics Sales Market Share Forecast by Country (2027-2032) Table 127. North America Specialty Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Specialty Generics Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Specialty Generics Market Share by Country (2021-2026) Table 130. North America Specialty Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Specialty Generics Market Share Forecast by Country (2027-2032) Table 132. Europe Specialty Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe Specialty Generics Sales by Country (2021-2026) & (K Units) Table 134. Europe Specialty Generics Sales Market Share by Country (2021-2026) Table 135. Europe Specialty Generics Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe Specialty Generics Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Specialty Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Specialty Generics Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Specialty Generics Market Share by Country (2021-2026) Table 140. Europe Specialty Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Specialty Generics Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Specialty Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Specialty Generics Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific Specialty Generics Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Specialty Generics Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific Specialty Generics Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Specialty Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Specialty Generics Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Specialty Generics Market Share by Country (2021-2026) Table 150. Asia-Pacific Specialty Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Specialty Generics Market Share Forecast by Country (2027-2032) Table 152. Latin America Specialty Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America Specialty Generics Sales by Country (2021-2026) & (K Units) Table 154. Latin America Specialty Generics Sales Market Share by Country (2021-2026) Table 155. Latin America Specialty Generics Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America Specialty Generics Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Specialty Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Specialty Generics Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Specialty Generics Market Share by Country (2021-2026) Table 160. Latin America Specialty Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Specialty Generics Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Specialty Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Specialty Generics Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Specialty Generics Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Specialty Generics Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa Specialty Generics Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Specialty Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Specialty Generics Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Specialty Generics Market Share by Country (2021-2026) Table 170. Middle East and Africa Specialty Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Specialty Generics Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Specialty Generics Distributors List Table 175. Specialty Generics Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Specialty Generics Image Figure 2. Global Specialty Generics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Specialty Generics Market Size (2021-2032) & (US$ Million) Figure 4. Global Specialty Generics Sales (2021-2032) & (K Units) Figure 5. Injectables Image Figure 6. Global Injectables Sales YoY Growth (2021-2032) & (K Units) Figure 7. Oral Image Figure 8. Global Oral Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Specialty Generics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Specialty Generics Market Share by Type 2025 VS 2032 Figure 13. North America Specialty Generics Sales Market Share in Volume by Type in 2025 Figure 14. North America Specialty Generics Sales Market Share in Value by Type in 2025 Figure 15. Europe Specialty Generics Sales Market Share in Volume by Type in 2025 Figure 16. Europe Specialty Generics Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Specialty Generics Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Specialty Generics Sales Market Share in Value by Type in 2025 Figure 19. Latin America Specialty Generics Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Specialty Generics Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Specialty Generics Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Specialty Generics Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Specialty Generics Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospital Pharmacies Image Figure 28. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 29. Specialty Pharmacies Image Figure 30. Global Specialty Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Specialty Generics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Specialty Generics Market Share by Application 2025 VS 2032 Figure 33. North America Specialty Generics Sales Market Share in Volume by Application in 2025 Figure 34. North America Specialty Generics Sales Market Share in Value by Application in 2025 Figure 35. Europe Specialty Generics Sales Market Share in Volume by Application in 2025 Figure 36. Europe Specialty Generics Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Specialty Generics Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Specialty Generics Sales Market Share in Value by Application in 2025 Figure 39. Latin America Specialty Generics Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Specialty Generics Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Specialty Generics Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Specialty Generics Sales Market Share in Value by Application in 2025 Figure 43. North America Specialty Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Specialty Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Specialty Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Specialty Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Specialty Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Specialty Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Specialty Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Specialty Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Specialty Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Specialty Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Specialty Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Specialty Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Specialty Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Specialty Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Specialty Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Specialty Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Specialty Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Specialty Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Specialty Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Specialty Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Specialty Generics Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Specialty Generics Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Injectables
  • Oral
  • Others
Applications
  • Retail Pharmacies
  • Hospital Pharmacies
  • Specialty Pharmacies
Companies covered
  • Akorn, Inc.
  • Apotex Corp.
  • Endo International plc.
  • Mallinckrodt
  • Sandoz International GmbH
  • Valeant Pharmaceuticals
  • Pfizer, Inc.
  • Mylan N.V.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceuticals Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Specialty Generics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Specialty Generics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Specialty Generics Market by Type
  6. 1.3.1 Injectables
  7. 1.3.2 Oral
  8. 1.3.3 Others
  9. 1.4 Global Specialty Generics Market Size by Type
  10. 1.4.1 Global Specialty Generics Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Specialty Generics Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Specialty Generics Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Specialty Generics Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Specialty Generics Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Specialty Generics Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Specialty Generics Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Specialty Generics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Specialty Generics Industry Trends
  2. 2.2 Specialty Generics Industry Drivers
  3. 2.3 Specialty Generics Industry Opportunities and Challenges
  4. 2.4 Specialty Generics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Specialty Generics Revenue (2021-2026)
  2. 3.2 Global Top Players by Specialty Generics Sales (2021-2026)
  3. 3.3 Global Top Players by Specialty Generics Price (2021-2026)
  4. 3.4 Global Specialty Generics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Specialty Generics Major Company Production Sites & Headquarters
  6. 3.6 Global Specialty Generics Company, Product Type & Application
  7. 3.7 Global Specialty Generics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Specialty Generics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Specialty Generics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Specialty Generics Tier 1, Tier 2, and Tier 3
4 Specialty Generics Regional Status and Outlook
  1. 4.1 Global Specialty Generics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Specialty Generics Historic Market Size by Region
  3. 4.2.1 Global Specialty Generics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Specialty Generics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Specialty Generics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Specialty Generics Forecasted Market Size by Region
  7. 4.3.1 Global Specialty Generics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Specialty Generics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Specialty Generics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Specialty Generics by Application
  1. 5.1 Specialty Generics Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Specialty Pharmacies
  5. 5.2 Global Specialty Generics Market Size by Application
  6. 5.2.1 Global Specialty Generics Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Specialty Generics Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Specialty Generics Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Specialty Generics Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Specialty Generics Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Specialty Generics Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Specialty Generics Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Specialty Generics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Akorn, Inc.
  2. 6.1.1 Akorn, Inc. Company Information
  3. 6.1.2 Akorn, Inc. Business Overview
  4. 6.1.3 Akorn, Inc. Specialty Generics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Akorn, Inc. Specialty Generics Product Portfolio
  6. 6.1.5 Akorn, Inc. Recent Developments
  7. 6.2 Apotex Corp.
  8. 6.2.1 Apotex Corp. Company Information
  9. 6.2.2 Apotex Corp. Business Overview
  10. 6.2.3 Apotex Corp. Specialty Generics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Apotex Corp. Specialty Generics Product Portfolio
  12. 6.2.5 Apotex Corp. Recent Developments
  13. 6.3 Endo International plc.
  14. 6.3.1 Endo International plc. Company Information
  15. 6.3.2 Endo International plc. Business Overview
  16. 6.3.3 Endo International plc. Specialty Generics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Endo International plc. Specialty Generics Product Portfolio
  18. 6.3.5 Endo International plc. Recent Developments
  19. 6.4 Mallinckrodt
  20. 6.4.1 Mallinckrodt Company Information
  21. 6.4.2 Mallinckrodt Business Overview
  22. 6.4.3 Mallinckrodt Specialty Generics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mallinckrodt Specialty Generics Product Portfolio
  24. 6.4.5 Mallinckrodt Recent Developments
  25. 6.5 Sandoz International GmbH
  26. 6.5.1 Sandoz International GmbH Company Information
  27. 6.5.2 Sandoz International GmbH Business Overview
  28. 6.5.3 Sandoz International GmbH Specialty Generics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sandoz International GmbH Specialty Generics Product Portfolio
  30. 6.5.5 Sandoz International GmbH Recent Developments
  31. 6.6 Valeant Pharmaceuticals
  32. 6.6.1 Valeant Pharmaceuticals Company Information
  33. 6.6.2 Valeant Pharmaceuticals Business Overview
  34. 6.6.3 Valeant Pharmaceuticals Specialty Generics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Valeant Pharmaceuticals Specialty Generics Product Portfolio
  36. 6.6.5 Valeant Pharmaceuticals Recent Developments
  37. 6.7 Pfizer, Inc.
  38. 6.7.1 Pfizer, Inc. Company Information
  39. 6.7.2 Pfizer, Inc. Business Overview
  40. 6.7.3 Pfizer, Inc. Specialty Generics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer, Inc. Specialty Generics Product Portfolio
  42. 6.7.5 Pfizer, Inc. Recent Developments
  43. 6.8 Mylan N.V.
  44. 6.8.1 Mylan N.V. Company Information
  45. 6.8.2 Mylan N.V. Business Overview
  46. 6.8.3 Mylan N.V. Specialty Generics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mylan N.V. Specialty Generics Product Portfolio
  48. 6.8.5 Mylan N.V. Recent Developments
  49. 6.9 Sun Pharmaceutical Industries Ltd.
  50. 6.9.1 Sun Pharmaceutical Industries Ltd. Company Information
  51. 6.9.2 Sun Pharmaceutical Industries Ltd. Business Overview
  52. 6.9.3 Sun Pharmaceutical Industries Ltd. Specialty Generics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sun Pharmaceutical Industries Ltd. Specialty Generics Product Portfolio
  54. 6.9.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  55. 6.10 Teva Pharmaceuticals Industries
  56. 6.10.1 Teva Pharmaceuticals Industries Company Information
  57. 6.10.2 Teva Pharmaceuticals Industries Business Overview
  58. 6.10.3 Teva Pharmaceuticals Industries Specialty Generics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Teva Pharmaceuticals Industries Specialty Generics Product Portfolio
  60. 6.10.5 Teva Pharmaceuticals Industries Recent Developments
7 North America by Country
  1. 7.1 North America Specialty Generics Sales by Country
  2. 7.1.1 North America Specialty Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Specialty Generics Sales by Country (2021-2026)
  4. 7.1.3 North America Specialty Generics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Specialty Generics Market Size by Country
  6. 7.2.1 North America Specialty Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Specialty Generics Market Size by Country (2021-2026)
  8. 7.2.3 North America Specialty Generics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Specialty Generics Sales by Country
  2. 8.1.1 Europe Specialty Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Specialty Generics Sales by Country (2021-2026)
  4. 8.1.3 Europe Specialty Generics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Specialty Generics Market Size by Country
  6. 8.2.1 Europe Specialty Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Specialty Generics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Specialty Generics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Specialty Generics Sales by Country
  2. 9.1.1 Asia-Pacific Specialty Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Specialty Generics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Specialty Generics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Specialty Generics Market Size by Country
  6. 9.2.1 Asia-Pacific Specialty Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Specialty Generics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Specialty Generics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Specialty Generics Sales by Country
  2. 10.1.1 South America Specialty Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Specialty Generics Sales by Country (2021-2026)
  4. 10.1.3 South America Specialty Generics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Specialty Generics Market Size by Country
  6. 10.2.1 South America Specialty Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Specialty Generics Market Size by Country (2021-2026)
  8. 10.2.3 South America Specialty Generics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Specialty Generics Sales by Country
  2. 11.1.1 Middle East and Africa Specialty Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Specialty Generics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Specialty Generics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Specialty Generics Market Size by Country
  6. 11.2.1 Middle East and Africa Specialty Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Specialty Generics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Specialty Generics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Specialty Generics Value Chain Analysis
  2. 12.1.1 Specialty Generics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Specialty Generics Production Mode & Process
  7. 12.2 Specialty Generics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Specialty Generics Distributors
  10. 12.2.3 Specialty Generics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst